Q3 2026 13F · SEC CIK 2010453
Patrick M Sweeney & Associates, Inc
Wealth managerFiled 2026-10-22 for Q3 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $177.4M
- Reported positions
- 177
- Top holdings a year, 3 yrs
- +15.1%
- Assets under management
- $252.5M
Patrick M Sweeney & Associates, Inc is a wealth manager that reported 177 positions worth $177.4M in its Q3 2026 13F, filed 2026-10-22. Its largest holdings were Apple Inc (AAPL, 6.9%), Abbott Laboratories (ABT, 4.2%), Merck & Co Inc (MRK, 3.9%). A portfolio copying its top holdings returned 15.1% a year over the last 3 years, against 18.8% for the S&P 500.
Patrick M Sweeney & Associates, Inc holdings largest 50 of 177 positions.
Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Patrick M Sweeney & Associates, Inc bought and sold in Q3 2026, against Q2 2026.
New positions
Q2 2026's filing was too long to tell new positions apart.
Added to
- NVDA Nvidia Corporation+10.0% shares
- PFE Pfizer Inc+7.4% shares
Reduced
- BX Blackstone Inc-7.4% shares
Left the top 50
- XOM Exxon Mobil Corpwas 0.6%
- MCD Mcdonalds Corpwas 0.5%
- FDX Fedex Corpwas 0.5%
Share counts compared with the Q2 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +21.8% /yr
- S&P 500 +20.1%
- 3 years
- +15.1% /yr
- S&P 500 +18.8%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q3 2026 | $177.4M | 177 |
| Q2 2026 | $174.1M | 172 |
| Q1 2026 | $156.0M | 164 |
| Q4 2025 | $159.9M | 159 |
| Q3 2025 | $154.7M | 159 |
| Q2 2025 | $145.4M | 156 |
| Q1 2025 | $133.9M | 147 |
| Q4 2024 | $133.5M | 147 |
| Q3 2024 | $136.1M | 151 |
| Q2 2024 | $123.7M | 139 |
| Q1 2024 | $121.6M | 134 |
| Q4 2023 | $109.3M | 127 |
Questions about Patrick M Sweeney & Associates, Inc's portfolio
What stocks does Patrick M Sweeney & Associates, Inc own?
Patrick M Sweeney & Associates, Inc's latest 13F, for Q3 2026 and filed Oct 22, 2026, lists 177 positions worth $177.4M. The largest are Apple Inc (AAPL) at 6.9%, Abbott Laboratories (ABT) at 4.2%, Merck & Co Inc (MRK) at 3.9%, Abbvie Inc (ABBV) at 3.9% and Bank of Amer Corp (BAC) at 3.7%.
What did Patrick M Sweeney & Associates, Inc buy last quarter?
In Q3 2026, Patrick M Sweeney & Associates, Inc added Nvidia Corporation (NVDA) (+10.0% shares) and Pfizer Inc (PFE) (+7.4% shares), compared with its Q2 2026 filing.
What did Patrick M Sweeney & Associates, Inc sell last quarter?
In Q3 2026, Patrick M Sweeney & Associates, Inc cut from its top 50 Exxon Mobil Corp (XOM), cut from its top 50 Mcdonalds Corp (MCD), cut from its top 50 Fedex Corp (FDX) and Blackstone Inc (BX) (-7.4% shares), compared with its Q2 2026 filing.
How has Patrick M Sweeney & Associates, Inc's portfolio performed?
A portfolio copying Patrick M Sweeney & Associates, Inc's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.1% a year over the last 3 years, against +18.8% for the S&P 500. Over 1 year: +21.8% against +20.1%.
When is Patrick M Sweeney & Associates, Inc's next 13F filing due?
13F filings are due 45 days after each quarter ends. Patrick M Sweeney & Associates, Inc's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.
How much money does Patrick M Sweeney & Associates, Inc manage?
Patrick M Sweeney & Associates, Inc reported $252.5M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $177.4M.